Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Population”

1,717 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,717 results

Not applicableNot Yet RecruitingNCT06881940
What this trial is testing

Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab

Who this might be right for
Cancer Therapy-Related Cardiac Dysfunction
Instituto Nacional de Cardiologia Ignacio Chavez 284
Not applicableStudy completedNCT00661817
What this trial is testing

Evaluating a Blood Pressure Reduction and Weight Loss Program in a Low Income, Ethnically Diverse Population (The Be Fit, Be Well [BFBW] Study)

Who this might be right for
ObesityHypertension
Washington University School of Medicine 365
Large-scale testing (Phase 3)Study completedNCT00168818
What this trial is testing

Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

Who this might be right for
ThromboembolismArthroplasty, Replacement, Hip
Boehringer Ingelheim 3,494
Not applicableStudy completedNCT04701086
What this trial is testing

3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

Who this might be right for
Dry Eye Syndromes
Santen SAS 83
Large-scale testing (Phase 3)Study completedNCT03197818
What this trial is testing

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)

Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)
Chiesi Farmaceutici S.p.A. 708
Large-scale testing (Phase 3)Study completedNCT01202188
What this trial is testing

Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 2,144
Large-scale testing (Phase 3)Ended earlyNCT00673920
What this trial is testing

Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 314
Large-scale testing (Phase 3)Active Not RecruitingNCT04033445
What this trial is testing

Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Janssen Research & Development, LLC 1,064
Large-scale testing (Phase 3)Study completedNCT04512001
What this trial is testing

MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 604
Testing effectiveness (Phase 2)WithdrawnNCT04655807
What this trial is testing

JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT02493712
What this trial is testing

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Who this might be right for
Colitis, Ulcerative
Holy Stone Healthcare Co., Ltd 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT05379634
What this trial is testing

Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies

Who this might be right for
Myositis
Janssen Research & Development, LLC 36
Large-scale testing (Phase 3)Study completedNCT00529451
What this trial is testing

Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg

Who this might be right for
Hypertension
Novartis 1,613
Large-scale testing (Phase 3)Study completedNCT00092781
What this trial is testing

MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)

Who this might be right for
Osteoarthritis
Organon and Co 500
Testing effectiveness (Phase 2)Study completedNCT00695305
What this trial is testing

An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks

Who this might be right for
Atherosclerosis
GlaxoSmithKline 83
Large-scale testing (Phase 3)Ended earlyNCT03715153
What this trial is testing

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.

Who this might be right for
Autism Spectrum Disorder (ASD)
Institut de Recherches Internationales Servier 211
Large-scale testing (Phase 3)Ended earlyNCT00813111
What this trial is testing

Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast Augmentation

Who this might be right for
Pain
Pacira Pharmaceuticals, Inc 136
Large-scale testing (Phase 3)Study completedNCT02091739
What this trial is testing

Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions

Who this might be right for
Chronic Troublesome SialorrheaParkinson's DiseasePost-stroke+1 more
Merz Pharmaceuticals GmbH 184
Not applicableStudy completedNCT04752592
What this trial is testing

Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB

Who this might be right for
Tuberculosis, Pulmonary
Norwegian Institute of Public Health 9,097
Large-scale testing (Phase 3)Ended earlyNCT04181762
What this trial is testing

Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 275
Next Page